XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.2
Share-based compensation
6 Months Ended
Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based compensation

14. Share-based compensation

The following tables present the detail of share-based compensation by line item in the condensed consolidated statements of operations and comprehensive income (loss) as well as by award type:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Cost of sales

 

$

180

 

 

$

132

 

 

$

367

 

 

$

257

 

Sales and marketing

 

 

692

 

 

 

473

 

 

 

1,302

 

 

 

922

 

General and administrative

 

 

4,564

 

 

 

4,249

 

 

 

9,128

 

 

 

7,294

 

Research and development

 

 

413

 

 

 

361

 

 

 

737

 

 

 

658

 

Total

 

$

5,849

 

 

$

5,215

 

 

$

11,534

 

 

$

9,131

 

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock options

 

$

926

 

 

$

1,241

 

 

$

3,038

 

 

$

1,863

 

Time-based restricted stock awards and units

 

 

2,951

 

 

 

1,789

 

 

 

4,657

 

 

 

3,236

 

Performance-based restricted stock awards and units

 

 

 

 

 

270

 

 

 

 

 

 

759

 

Market-based restricted stock units

 

 

1,576

 

 

 

1,604

 

 

 

2,923

 

 

 

2,557

 

Stock purchase plan

 

 

396

 

 

 

311

 

 

 

916

 

 

 

716

 

Total

 

$

5,849

 

 

$

5,215

 

 

$

11,534

 

 

$

9,131

 

During the three months ended June 30, 2019 and 2018, the Company issued 40,812 and 80,444 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards and units. During the six months ended June 30, 2019 and 2018, the Company issued 251,893 and 206,955 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards and units.

On August 5, the Company entered into an employment agreement with its new President of Global Spine and awarded restricted stock units and stock options valued at approximately $1.5 million as inducement grants.

Share-Based Compensation Modifications

During the first quarter of 2019, the Company entered into a Transition and Retirement Agreement (the “Retirement Agreement”) with the Company’s President and Chief Executive Officer.  As part of the Retirement Agreement, certain time-based stock options and restricted stock awards were modified to accelerate the vesting to the retirement date. In addition, stock options were modified to extend the post-termination exercise period from 18 months under a standard qualified retirement to up to four years, dependent upon the remaining contractual term of the options. The Company recognized approximately $1.5 million and $3.7 million in share-based compensation expense during the three and six months ended June 30, 2019, related to the Retirement Agreement, which was charged to general and administrative expense in the condensed consolidated statements of operations and comprehensive income (loss).